Total Payments
$397,666
2024 Payments
$69,133
Companies
13
Transactions
265
Medicare Patients
395
Medicare Billing
$68,987
Payment Breakdown by Category
Consulting$267,102 (67.2%)
Other$71,268 (17.9%)
Travel$55,866 (14.0%)
Food & Beverage$3,430 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $267,102 | 73 | 67.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,268 | 73 | 17.9% |
| Travel and Lodging | $55,866 | 61 | 14.0% |
| Food and Beverage | $3,430 | 58 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim International GmbH | $218,764 | 120 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $145,105 | 100 | $0 (2024) |
| GlaxoSmithKline, LLC. | $15,041 | 9 | $0 (2024) |
| ABBVIE INC. | $7,065 | 13 | $0 (2024) |
| Boehringer Ingelheim Do Brasil Quimica e Farmaceutical Ltda. | $4,200 | 2 | $0 (2021) |
| Boehringer Ingelheim Canada Ltd.Ltee | $2,250 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $2,200 | 1 | $0 (2024) |
| Roche Products Limited | $1,500 | 1 | $0 (2022) |
| CSL Behring | $1,115 | 11 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $243.34 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $69,133 | 52 | Boehringer Ingelheim International GmbH ($54,404) |
| 2023 | $48,260 | 28 | Boehringer Ingelheim International GmbH ($30,444) |
| 2022 | $49,809 | 38 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28,220) |
| 2021 | $47,378 | 35 | Boehringer Ingelheim International GmbH ($25,650) |
| 2020 | $50,097 | 27 | Boehringer Ingelheim International GmbH ($26,146) |
| 2019 | $105,399 | 63 | Boehringer Ingelheim Pharmaceuticals, Inc. ($57,473) |
| 2018 | $27,590 | 22 | Boehringer Ingelheim International GmbH ($18,022) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,128.14 | General |
| 12/23/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $3,150.75 | General |
| 12/23/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 12/23/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $323.50 | General |
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $2,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Travel and Lodging | In-kind items and services | $323.50 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Travel and Lodging | In-kind items and services | $11,189.61 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Travel and Lodging | In-kind items and services | $487.59 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $325.00 | General |
| 11/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $118.02 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Food and Beverage | In-kind items and services | $103.95 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Food and Beverage | In-kind items and services | $52.67 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Food and Beverage | In-kind items and services | $103.95 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Food and Beverage | In-kind items and services | $67.19 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $50.90 | General |
| 10/28/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $33.33 | General |
| 07/19/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $13,800.00 | General |
| Category: RESPIRATORY | ||||||
| 06/16/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Travel and Lodging | In-kind items and services | $1,979.82 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $794.43 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Food and Beverage | In-kind items and services | $49.09 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $262.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 106 | 170 | $167,058 | $19,236 |
| 2022 | 1 | 60 | 119 | $114,240 | $13,073 |
| 2021 | 4 | 105 | 183 | $170,150 | $21,736 |
| 2020 | 5 | 124 | 187 | $91,437 | $14,942 |
Total Patients
395
Total Services
659
Medicare Billing
$68,987
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 72 | 134 | $128,640 | $15,535 | 12.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 15 | 15 | $20,400 | $2,017 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 19 | 21 | $18,018 | $1,684 | 9.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 60 | 119 | $114,240 | $13,073 | 11.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 65 | 128 | $122,880 | $15,228 | 12.4% |
| 99234 | Hospital observation or inpatient care low severity, 40 minutes per day | Facility | 2021 | 12 | 25 | $14,600 | $2,830 | 19.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $19,800 | $2,594 | 13.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 15 | $12,870 | $1,084 | 8.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 41 | 69 | $39,330 | $4,457 | 11.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 41 | $18,655 | $3,667 | 19.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 22 | 28 | $17,920 | $2,387 | 13.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $9,680 | $1,910 | 19.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 23 | 27 | $4,158 | $1,801 | 43.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,694 | $719.46 | 42.5% |
About Dr. Elizabeth Volkmann, MD
Dr. Elizabeth Volkmann, MD is a Internal Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2009. The National Provider Identifier (NPI) number assigned to this provider is 1932336955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Volkmann, MD has received a total of $397,666 in payments from pharmaceutical and medical device companies, with $69,133 received in 2024. These payments were reported across 265 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($267,102).
As a Medicare-enrolled provider, Volkmann has provided services to 395 Medicare beneficiaries, totaling 659 services with total Medicare billing of $68,987. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Los Angeles, CA
- Active Since 06/17/2009
- Last Updated 09/05/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932336955
Products in Payments
- OFEV (Drug) $342,221
- NINTEDANIB (Drug) $3,000
- Privigen (Biological) $1,115
- Cimzia (Drug) $115.68
- ILARIS (Biological) $94.12
- BENLYSTA (Biological) $91.15
- COSENTYX (Drug) $91.15
- COSENTYX (Biological) $58.07
- SAPHNELO (Biological) $50.66
- Actemra (Biological) $16.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Los Angeles
Dr. Thomas Magee, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Julio Gutierrez, Md, MD
Internal Medicine — Payments: $920,439
Internal Medicine $920,439
Dr. Mohammad Kamgar, M.d, M.D
Internal Medicine — Payments: $471,176
Internal Medicine $471,176
Dr. Caroline Piatek, M.d,, M.D,
Internal Medicine — Payments: $468,526
Internal Medicine $468,526
Gottfried Konecny, Md, MD
Internal Medicine — Payments: $399,651
Internal Medicine $399,651
Ivan Ho, Md, MD
Internal Medicine — Payments: $378,999
Internal Medicine $378,999